drugset / Trial / NCT06577935
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to determine the effect of treatment with AGA2118 versus placebo at Month 12 on lumbar spine bone mineral density (BMD) in postmenopausal women with low bone mass.
Timeline
- Start
- 2024-10-31
- Primary completion
- 2026-12
- Completion
- 2028-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGA2118 | Unknown | — | Subcutaneous |